COCH insider filings
Envoy Medical, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2026-08-26. Screen COCH transaction legs live →
Insider transaction summary — last 90 days
2026-07-10 to 2026-10-08, from the filings listed below: 1 insider filing (Forms 3/4/5). Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 1.
By insider — same window
Open-market purchase/sale legs on non-derivative securities, grouped by the filing's reporting owner(s); joint filings appear once. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Insider | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|
| Potashnick Robert — CAO & VP of Finance | 1 | — | — | 1 |
Recent insider filings — Envoy Medical, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-26 | 4 | Potashnick Robert — CAO & VP of Finance | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2026-06-23 | 4 | Lucas Brent T. — Chief Executive Officer, Director | Grant/award (A): 1,000,000 (derivative) @ $0 · Grant/award (A): 1,000,000 (derivative) @ $0 | EDGAR |
| 2026-06-04 | 4 | Lucas Brent T. — Chief Executive Officer, Director | Grant/award (A): 32,856 @ $0.60 | EDGAR |
| 2026-04-17 | 4 | McKhann Chas — Director | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Patel Mona Chetan — Director | Purchase (P): 312,500 @ $0.40 · Purchase (P): 187,500 (derivative) @ $0 · Purchase (P): 312,500 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Potashnick Robert — Interim CFO | Purchase (P): 212,500 @ $0.40 · Purchase (P): 127,500 (derivative) @ $0 · Purchase (P): 212,500 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Lucas Brent T. — Chief Executive Officer, Director | Purchase (P): 62,500 @ $0.40 · Purchase (P): 37,500 (derivative) @ $0 · Purchase (P): 62,500 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | BRYNELSEN CHARLES — Director | Purchase (P): 1,000,000 @ $0.40 · Purchase (P): 600,000 (derivative) @ $0 · Purchase (P): 1,000,000 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | Kantor Susan — Director | Purchase (P): 96,150 @ $0.40 · Purchase (P): 57,690 (derivative) @ $0 · Purchase (P): 96,150 (derivative) @ $0 | EDGAR |
| 2026-02-17 | 4 | TAYLOR GLEN A — 10% owner | Purchase (P): 18,750,000 @ $0.40 · Purchase (P): 11,250,000 (derivative) @ $0 · Purchase (P): 18,750,000 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | Potashnick Robert — Interim CFO | Grant/award (A): 15,000 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | Lucas Brent T. — Chief Executive Officer, Director | Grant/award (A): 200,000 (derivative) @ $0 | EDGAR |
| 2025-12-10 | 4 | Lucas Brent T. — Chief Executive Officer, Director | Grant/award (A): 18,105 @ $0.71 | EDGAR |
| 2025-12-05 | 4 | Smith-Gomez Janis — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-12-05 | 4 | Crowe Michael Curtis — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-12-05 | 4 | Patel Mona Chetan — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-12-05 | 4 | BRYNELSEN CHARLES — Director | Grant/award (A): 62,500 (derivative) @ $0 | EDGAR |
| 2025-12-05 | 4 | Kantor Susan — Director | Grant/award (A): 62,500 (derivative) @ $0 | EDGAR |
| 2025-09-08 | 4 | TAYLOR GLEN A — Director, 10% owner | Disposition to issuer (D): 500,000 (derivative) · Grant/award (A): 500,000 (derivative) · Disposition to issuer (D): 250,000 (derivative) · Grant/award (A): 250,000 (derivative) · Disposition to issuer (D): 250,000 (derivative) · Grant/award (A): 250,000 (derivative) · +8 more | EDGAR |
| 2025-07-08 | 4 | TAYLOR GLEN A — Director, 10% owner | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4 | Patel Mona Chetan — Director | Purchase (P): 2,500 @ $1.47 | EDGAR |
| 2025-06-10 | 4 | Patel Mona Chetan — Director | Purchase (P): 10,000 @ $1.46 | EDGAR |
| 2025-06-09 | 4 | Lucas Brent T. — Chief Executive Officer, Director | Grant/award (A): 5,165 @ $1.94 · Grant/award (A): 7,742 @ $1.29 | EDGAR |
| 2025-05-27 | 4 | BRYNELSEN CHARLES — Director | Purchase (P): 2,000 @ $1.68 · Purchase (P): 13,000 @ $1.64 · Purchase (P): 35,000 @ $1.65 | EDGAR |
| 2025-03-13 | 4 | TAYLOR GLEN A — Director, 10% owner | Grant/award (A): 750,000 (derivative) @ $0 | EDGAR |
| 2024-12-26 | 4 | Anzu SPAC GP I LLC — 10% owner Haring-Smith Whitney — 10% owner | Conversion (C): 1,028,986 @ $0 · Other (J): 2,028,986 @ $0 · Conversion (C): 373,333 (derivative) @ $0 | EDGAR |
| 2024-12-26 | 4 | Kantor Susan — Director | Other (J): 34,705 @ $0 | EDGAR |
| 2024-12-17 | 4 | TAYLOR GLEN A — Director, 10% owner | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2024-12-13 | 4 | Lucas Brent T. — Chief Executive Officer, Director | Purchase (P): 94,293 (derivative) @ $0.06 · Purchase (P): 16,694 (derivative) @ $0.06 | EDGAR |
| 2024-11-22 | 4 | Patel Mona Chetan — Director | Purchase (P): 2,500 @ $2.28 | EDGAR |
| 2024-11-21 | 4 | Anzu SPAC GP I LLC — 10% owner Haring-Smith Whitney — 10% owner | Other (J): 1,000,000 @ $0 | EDGAR |
| 2024-11-21 | 4 | Kantor Susan — Director | Other (J): 18,182 @ $0 | EDGAR |
| 2024-09-11 | 4 | Patel Mona Chetan — Director | Purchase (P): 1,000 @ $3.20 · Purchase (P): 4,000 @ $3.33 | EDGAR |
| 2024-08-29 | 4 | TAYLOR GLEN A — Director, 10% owner | Grant/award (A): 500,000 (derivative) @ $0 | EDGAR |
| 2024-08-12 | 4 | Crowe Michael Curtis — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2024-07-24 | 4 | TAYLOR GLEN A — Director, 10% owner | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2024-06-26 | 4 | Lucas Brent T. — Chief Executive Officer, Director | Other (J): 74,784 @ $0 · Other (J): 10,176 @ $0 | EDGAR |
| 2024-05-28 | 4 | TAYLOR GLEN A — Director, 10% owner | Grant/award (A): 250,000 (derivative) @ $0 | EDGAR |
| 2024-03-04 | 4 | TAYLOR GLEN A — Director, 10% owner | Purchase (P): 500,000 (derivative) @ $0 | EDGAR |
| 2023-12-04 | 4/A | TAYLOR GLEN A — Director, 10% owner | Other (J): 100,000 (derivative) @ $10 | EDGAR |
| 2023-11-24 | 4 | Lucas Brent T. — Chief Executive Officer, Director | Purchase (P): 10,000 @ $0.98 · Purchase (P): 2,380 @ $0.92 | EDGAR |
| 2023-11-22 | 4 | TAYLOR GLEN A — Director, 10% owner | Purchase (P): 100,000 (derivative) @ $10 | EDGAR |
| 2023-10-17 | 4 | Lucas Brent T. — Chief Executive Officer, Director | Grant/award (A): 879,749 (derivative) @ $0 | EDGAR |
| 2023-10-17 | 4 | Patel Mona Chetan — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-10-17 | 4 | Smith-Gomez Janis — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2023-10-17 | 4 | BRYNELSEN CHARLES — Director | Grant/award (A): 62,500 (derivative) @ $0 | EDGAR |
| 2023-10-17 | 4 | Kantor Susan — Director | Grant/award (A): 62,500 (derivative) @ $0 | EDGAR |
| 2023-10-17 | 4 | Wells David R. — Chief Financial Officer | Grant/award (A): 293,250 (derivative) @ $0 | EDGAR |
| 2023-10-03 | 4 | TAYLOR GLEN A — Director, 10% owner | Conversion (C): 1,000,000 (derivative) @ $10 · Conversion (C): 869,565 (derivative) @ $10 | EDGAR |
| 2023-10-03 | 4 | DEWBREY DIANE L — Director | Conversion (C): 25,000 @ $0 · Conversion (C): 25,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — Envoy Medical, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-10-07 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-27 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-30 | 8-K | 1.02 — Termination of a Material Definitive Agreement 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-25 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-22 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2026-05-18 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-21 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-03-31 | 8-K | 4.01 — Changes in Registrant's Certifying Accountant 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=COCH returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →